Saimirra Innopharm Private Limited, a active private limited company, was established on 06 March 2000 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TN2000PTC044315. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹19.25 Cr and a paid-up capital of ₹16.00 Cr.
It upholds a compliant status. Employing 154 professional, Its leadership includes Ayyavu Rajavel (Alternate Director), Shanmugam Muthusamy (Director), Jaganathan Jayaseelan (Director). Past directors included Subbaraaman Vijayalakshmi, Ramesh Shankar Gadgil, Jaganathan Jayaseelan. It holds ₹175.36 Cr open charges and ₹245.87 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 288 & 299, Sidco Estate Ambattur, Chennai, Tamil Nadu, 600098.
U24232TN2000PTC044315
044315
06 March 2000
₹19.25 Cr
₹16.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Saimirra Innopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayyavu Rajavel | Alternate Director | 22 Oct 2012 | Current |
| Shanmugam Muthusamy | Director | 22 Oct 2012 | Current |
| Jaganathan Jayaseelan | Director | 18 Jul 2012 | Current |
| Thanigainathan Thirumurugan | Director | 14 Jun 2013 | Current |
| Bernice Sugirtha | Director | 09 Jul 2024 | Current |
| Abhishek Jain | Nominee Director | 19 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Aug 2012 | Past |
| Pramod Abcsdd | Director | 17 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Managing Director | 17 Aug 2012 | Past |
| Pramod Abcsdd | Director | 17 Aug 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saimirra Innopharm Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Saimirra Innopharm had a promoter holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,753,616,000.00
₹2,458,678,395.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2025 | Others | ₹160.00 Cr | Open |
| 31 May 2024 | Others | ₹15.00 Cr | Open |
| 02 Feb 2024 | Hdfc Bank Limited | ₹3.62 M | Open |
| 24 Feb 2023 | Others | ₹165.00 Cr | Satisfied |
| 25 Oct 2021 | Others | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Saimirra Innopharm has a workforce of 154 employees as of Mar 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Saimirra Innopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saimirra Innopharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 160.00 Cr registered on 10 Apr 2025 with Charge ID 101104921 was modified on 11 Sep 2025. was recorded as a recent event.
Abhishek Jain was appointed as a Nominee Director was appointed as a Nominee Director on 19 Jul 2025 & has been associated with this company since 5 months 12 days . was recorded as a recent event.
Progress on A charge registered on 24 Feb 2023 via Charge ID 100706380 with Others was fully satisfied on 05 May 2025. was documented.
The activity A charge with Others amounted to Rs. 160.00 Cr with Charge ID 101104921 was registered on 10 Apr 2025. was completed.
The activity Saimirra Innopharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Bernice Sugirtha was appointed as a Director was appointed as a Director on 09 Jul 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
The CIN of Saimirra Innopharm Private Limited is U24232TN2000PTC044315.
Saimirra Innopharm Private Limited is headquartered at 288 & 299, Sidco Estate Ambattur, Chennai, Tamil Nadu, 600098.
Saimirra Innopharm Private Limited was incorporated on 06 March 2000.
The current directors of Saimirra Innopharm Private Limited are
The primary industry of Saimirra Innopharm Private Limited is Manufacturing.
Saimirra Innopharm Private Limited is unlisted.
The authorized capital of Saimirra Innopharm Private Limited is ₹19.25 Cr, and the paid-up capital is ₹16.00 Cr.
The compliance status of Saimirra Innopharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX